Lee Financial CO Horizon Therapeutics Public LTD CO Transaction History

Lee Financial CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$58.92 - $84.67 $1,649 - $2,370	-28 Reduced 10.26%	245 $15,000
Q1 2022 May 11, 2022	SELL	$86.42 - $109.81 $4,061 - $5,161	-47 Reduced 14.69%	273 $29,000
Q4 2021 Feb 08, 2022	BUY	$98.56 - $119.91 $4,632 - $5,635	47 Added 17.22%	320 $34,000
Q2 2021 Aug 04, 2021	BUY	$86.24 - $95.92 $2,414 - $2,685	28 Added 11.43%	273 $26,000
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $3,232 - $4,296	45 Added 22.5%	245 $23,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $13,400 - $16,878	200 New	200 $15,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.